⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL992946 | 1.00 | — | — | |
| SCHEMBL13347079 | 1.00 | — | — | |
| SCHEMBL15280657 | 1.00 | — | — | |
| SCHEMBL4828480 | 1.00 | — | — | |
| SCHEMBL18058692 | 1.00 | — | — | |
| SCHEMBL19190722 | 1.00 | — | — | |
| SCHEMBL24240089 | 1.00 | — | — | |
| SCHEMBL15384524 | 1.00 | — | — | |
| SCHEMBL22100978 | 1.00 | — | — | |
| SCHEMBL9965214 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7652042-B2 | Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments | CANBAS CO., LTD. (JP) | 2010-01-26 | — | — | US | disclosed |